IL6R and rectal cancer: Furthermore, in the literature miR-34a has been reported as one of the most relevant downstream effectors of p53, which blocks the IL-6R/STAT3/miR-34 feedback loop resulting in inhibition of tumor progression in rectal cancer [49].